醣聯 Stock: price and insider trades · Taiwan
醣聯: what insiders have been doing
醣聯 is a Health Care company. Its directors and officers file their transactions with TWSE / TPEx (MOPS). Between 22 October 2025 and 22 October 2026, 2 insiders published 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of 醣聯 has been absent for the past year.
Across the 620 companies tracked on its exchange, the median is 2 filings; at 2 filings, this issuer sits right on that mark.
Every figure here comes from the filings published by TWSE / TPEx (MOPS) and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 88,566 sharesShareTPExTWMOPS:4168:115/02/06:張東玄:0uyam6b
- 88,566 sharesShareTPExTWMOPS:4168:115/02/06:蘇秀娥:1dgw2xr
- 240,000 sharesShareTPExTWMOPS:4168:109/03/31:楊玫君:1r0qdle
- 110,000 sharesShareTPExTWMOPS:4168:109/03/31:呂耀華:0pr9n96
- 110,000 sharesShareTPExTWMOPS:4168:109/03/31:劉亮吟:1yd0rmo
- 80,000 sharesShareTPExTWMOPS:4168:109/03/31:吳蒂芬:1un2xc0
- 500,000 sharesShareTPExTWMOPS:4168:105/01/21:台灣尖端先進生技醫藥股公司:1vfq4gw
- 40,000 sharesShareTPExTWMOPS:4168:105/01/06:吳蒂芬:0d2cna3
8 of 8 declarations
About 醣聯
醣聯 is a company listed on the XTAI market, specializing in the food technology sector. It focuses on the development and commercialization of innovative carbohydrate-based solutions.
